The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Biomolecules"
DOI: 10.3390/biom9090416
Abstract: Chronic inflammation is one of the main determinants of atherogenesis. The traditional medications for treatment of atherosclerosis are not very efficient in targeting atherosclerotic inflammation. Most of these drugs are non-selective, anti-inflammatory and immunosuppressive agents… read more here.
Keywords: inflammation; reduce inflammation; potential nanoparticles; nanoparticles reduce ... See more keywords